ArticleClinical and molecular hepatology2022
Current status and outcome of liver transplantation in South Korea.
Article in Clinical and molecular hepatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Preclinical Analysis of Bone Marrow-Derived Stem Cell Therapy Response and Transcriptomic Overlap Analysis in a Severe Alcoholic Hepatitis Mouse Model.Gut and liver · 2026Pooled it
- Anastomosis selection in liver transplantation for recipients with unusable recipient hepatic arteries: a bayesian network meta-analysis.BMC surgery · 2024Pooled it
- Outcomes of small-size graft in highly urgent living donor liver transplantation: Korean national data.Hepatobiliary surgery and nutrition · 2026Article
- Outcomes of highly urgent living donor liver transplantation in Korean national data.Hepatobiliary surgery and nutrition · 2026Article
- Outcomes of Highly Urgent ABO-Incompatible Living Donor Liver Transplantation in National Databases.Journal of Korean medical science · 2026Article
- Anatomical complexity of the right-lobe grafts: influence on the outcomes in living donor liver transplantation.Hepatobiliary surgery and nutrition · 2025Article
- Correspondence to letter to the editor on "Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation".Clinical and molecular hepatology · 2025Article
- Correspondence to editorial on "Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation".Clinical and molecular hepatology · 2025Article
- Appropriate Timing and Interval for Surveillance Colonoscopy after Liver Transplantation Based on a Single-Centre Experience.Canadian liver journal · 2025Article
- Number of Pretransplant Therapeutic Plasma Exchange Sessions Increase the Recurrence Risk of Hepatocellular Carcinoma in ABO-Incompatible Living Donor Liver Transplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2025Article
- Mortality and associated factors among patients who underwent liver transplantation in South Korea from 2017 to 2021: a retrospective observational study.Annals of surgical treatment and research · 2024Article
- Approach to Liver Transplantation: Is There a Difference between East and West?Journal of clinical medicine · 2024Review
- Comparison of Fibrinogen Concentrate and Cryoprecipitate on Major Thromboembolic Events after Living Donor Liver Transplantation.Journal of clinical medicine · 2023Article
- The Effect of Model for End-Stage Liver Disease 3.0 on Disparities between Patients with and without Hepatocellular Carcinoma in Korea.Yonsei medical journal · 2023Article
- Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity.Clinical and molecular hepatology · 2023Review
- How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease.Clinical and molecular hepatology · 2023Article
- Does mtori base immunosuppression offer survival advantage after liver transplantation for hepatocellular carcinoma? Systematic review and meta-analysis of randomized controlled trials.Hepatology forum · 2023Review
- The first successful report of liver transplantation from category III donation after circulatory death in South Korea: a case report.Korean journal of transplantation · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.